Could online exercise help heart failure patients get stronger at home?
NCT ID NCT04797481
First seen Jul 10, 2026 ยท Last updated Jul 10, 2026
Summary
This study tests whether a fully online exercise program is practical and acceptable for people with heart failure. Participants are randomly assigned to either a supervised online exercise group or a self-managed home exercise program for 8 weeks. The goal is to see if people stick with the program and find it helpful, before testing if it improves heart function and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- online exercise program
- What this could lead to
- If successful, this could provide a scalable, home-based rehabilitation option for people with heart failure, improving their physical independence and reducing hospital visits.
- What could go wrong
- This is a small pilot study with only 40 participants, so results may not apply to all heart failure patients. The online format may not suit everyone, and adherence could vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2023
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age \> 18 yrs. of either gender * Confirmed diagnosis (by echocardiography) of HF reduced left ventricular ejection fraction * Sinus rhythm N-Terminal pro-Brain Natriuretic Peptide (NTproBNP) is \>400 ng/L at the time of referral to the diagnostic clinic if in sinus rhythm. * Ability to exercise Exclusion Criteria: * Non-ambulant status * Current pregnancy * Scheduled major cardiac surgery * The presence of an ICD or CRT-D device * Severe pulmonary hypertension defined as systolic PAP of \>60 mmHg * NYHA function class IV * Lack of internet connection * Inability/unwillingness to give informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart failure are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sheffield Hallam University
Sheffield, Yorkshire, S10 2BP, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The impact of video-based cardiac rehabilitation education in patients with cardiovascular implantable electronic Devices(CIEDs)- a randomized controlled trial
- Effect of the use of dapagliflozin in diuresis, natriuresis and in ultrafiltration and peritoneal elimination of sodium, in patients with refractory heart failure
- Can a 10-Week coaching program ease the toll on heart failure caregivers?
- Can a 10-Second chest scan reveal hidden heart clues?
- Can AI help nurses guide At-Risk seniors to better care and lower costs?
- A Body-Scan test may reveal hidden fluid buildup, guiding early diuretic use